Defining the Eye-of-the-Tiger Sign

Kapil D. Sethi; Shyamal H. Mehta; John C. Morgan

doi:10.1001/jamaneurol.2015.0144

Defining the Eye-of-the-Tiger Sign

Kapil D. Sethi, Shyamal H. Mehta, John C. Morgan

Neurology

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	606
Number of pages	1
Journal	JAMA Neurology
Volume	72
Issue number	5
DOIs	https://doi.org/10.1001/jamaneurol.2015.0144
State	Published - May 2015

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1001/jamaneurol.2015.0144

Cite this

@article{8f8f5d0b90a04e37b94214643a8a6049,

title = "Defining the Eye-of-the-Tiger Sign",

author = "Sethi, {Kapil D.} and Mehta, {Shyamal H.} and Morgan, {John C.}",

note = "Funding Information: Drs Sethi and Morgan have both received grant support from the National Institutes of Health and National Parkinson Foundation. Funding Information: Author Affiliations: Movement Disorders Program, Department of Neurology, Georgia Regents University, Augusta (Sethi, Morgan); Movement Disorders Division, Department of Neurology, Mayo Clinic, Scottsdale, Arizona (Mehta). Corresponding Author: Kapil D. Sethi, MD, FRCP(UK), Movement Disorders Program, Department of Neurology, Georgia Regents University, 1429 Harper St, Augusta, GA 30912 (ksethi@gru.edu). Conflict of Interest Disclosures: Dr Sethi is a part-time employee of Merz Pharmaceuticals and has served as a consultant for Teva Pharmaceutical Industries, Impax Laboratories, Lundbeck, Synosia Therapeutics, and Veloxis Pharmaceuticals and as a speaker for Teva Pharmaceutical Industries. Dr Sethi has received grant support from Kyowa, Acadia Pharmaceuticals, and AbbVie. Dr Morgan has served as a consultant for Teva Pharmaceutical Industries, Lundbeck, and Veloxis Pharmaceuticals and as a speaker for Teva Pharmaceutical Industries. No other disclosures were reported. Funding/Support: Drs Sethi and Morgan have both received grant support from the National Institutes of Health and National Parkinson Foundation. Role of the Funder/Sponsor: The funders had no role in the preparation, review, or approval of the manuscript, and the decision to submit the manuscript for publication. 1. Pandey S, Byler DL, Hallett M. Hemidystonia with one eye-of-the-tiger sign. JAMA Neurol. 2014;71(12):1574-1575. 2. Sethi KD, Adams RJ, Loring DW, el Gammal T. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol. 1988;24(5): 692-694.",

year = "2015",

month = may,

doi = "10.1001/jamaneurol.2015.0144",

language = "English (US)",

volume = "72",

pages = "606",

journal = "JAMA Neurology",

issn = "2168-6149",

publisher = "American Medical Association",

number = "5",

}

TY - JOUR

T1 - Defining the Eye-of-the-Tiger Sign

AU - Sethi, Kapil D.

AU - Mehta, Shyamal H.

AU - Morgan, John C.

N1 - Funding Information: Drs Sethi and Morgan have both received grant support from the National Institutes of Health and National Parkinson Foundation. Funding Information: Author Affiliations: Movement Disorders Program, Department of Neurology, Georgia Regents University, Augusta (Sethi, Morgan); Movement Disorders Division, Department of Neurology, Mayo Clinic, Scottsdale, Arizona (Mehta). Corresponding Author: Kapil D. Sethi, MD, FRCP(UK), Movement Disorders Program, Department of Neurology, Georgia Regents University, 1429 Harper St, Augusta, GA 30912 (ksethi@gru.edu). Conflict of Interest Disclosures: Dr Sethi is a part-time employee of Merz Pharmaceuticals and has served as a consultant for Teva Pharmaceutical Industries, Impax Laboratories, Lundbeck, Synosia Therapeutics, and Veloxis Pharmaceuticals and as a speaker for Teva Pharmaceutical Industries. Dr Sethi has received grant support from Kyowa, Acadia Pharmaceuticals, and AbbVie. Dr Morgan has served as a consultant for Teva Pharmaceutical Industries, Lundbeck, and Veloxis Pharmaceuticals and as a speaker for Teva Pharmaceutical Industries. No other disclosures were reported. Funding/Support: Drs Sethi and Morgan have both received grant support from the National Institutes of Health and National Parkinson Foundation. Role of the Funder/Sponsor: The funders had no role in the preparation, review, or approval of the manuscript, and the decision to submit the manuscript for publication. 1. Pandey S, Byler DL, Hallett M. Hemidystonia with one eye-of-the-tiger sign. JAMA Neurol. 2014;71(12):1574-1575. 2. Sethi KD, Adams RJ, Loring DW, el Gammal T. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol. 1988;24(5): 692-694.

PY - 2015/5

Y1 - 2015/5

UR - http://www.scopus.com/inward/record.url?scp=84937217763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937217763&partnerID=8YFLogxK

U2 - 10.1001/jamaneurol.2015.0144

DO - 10.1001/jamaneurol.2015.0144

M3 - Letter

C2 - 25961178

AN - SCOPUS:84937217763

SN - 2168-6149

VL - 72

SP - 606

JO - JAMA Neurology

JF - JAMA Neurology

IS - 5

ER -

Defining the Eye-of-the-Tiger Sign

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this